Bio-Rad Laboratories (BIO) Cash from Investing Activities Growth (3y) (2012 - 2026)
Powered by 
Analysis
Bio-Rad Laboratories (BIO) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | -186.61% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | -126.34% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | -48.84% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 81.69% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | -14.06% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | -63.66% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -26.67% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -20.13% |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | 0.91% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -63.66% |
| Mar 31, 2026 | -9.77% |
| Dec 31, 2025 | 16.41% |
| Sep 30, 2025 | 21.36% |
| Jun 30, 2025 | 7.22% |
| Mar 31, 2025 | 26.06% |
| Dec 31, 2024 | 62.26% |
| Sep 30, 2024 | 11.86% |
| Jun 30, 2024 | 32.46% |
| Mar 31, 2024 | 3.74% |
| Dec 31, 2023 | 47.48% |
| Sep 30, 2023 | -28.15% |
| Jun 30, 2023 | 32.30% |
| Mar 31, 2023 | -78.35% |
| Dec 31, 2022 | 1.46% |
| Sep 30, 2022 | 7.00% |
| Jun 30, 2022 | -112.43% |
| Mar 31, 2022 | -242.95% |
| Dec 31, 2021 | -117.95% |
| Sep 30, 2021 | -40.22% |